-
PreScission Protease (PSP): Tag Cleavage for Protein Purific
2026-06-16
PreScission Protease (PSP) provides researchers with a reliable solution for removing fusion tags from recombinant proteins, a critical step in workflows requiring recovery of native protein structure and function. Its cold-active, HRV 3C protease backbone makes it suitable for sensitive targets but less appropriate where high-temperature activity or non-canonical cleavage is needed.
-
SGC-CBP30: Selective CREBBP/EP300 Bromodomain Inhibitor for
2026-06-16
SGC-CBP30 is a potent, selective CREBBP/EP300 bromodomain inhibitor designed for precise epigenetics and cancer biology research. By targeting transcriptional coactivators, it enables mechanistic studies of enhancer function and super-enhancer hijacking, with validated efficacy in relevant cell models.
-
Moxidectin: Macrocyclic Lactone Anthelmintic for Synergistic
2026-06-15
Moxidectin’s unique ability to elevate ergosterol biosynthesis in Candida albicans unlocks robust synergy with polyene antifungals, expanding its utility beyond traditional parasitic worm control. This article details experimental workflows, troubleshooting strategies, and comparative advantages for translational researchers leveraging APExBIO’s high-purity Moxidectin.
-
AMPK Inhibits Rather Than Induces Autophagy Under Energy Str
2026-06-15
This study overturns the prevailing model of AMPK function by demonstrating that AMPK activation suppresses, rather than induces, autophagy during glucose starvation. The findings redefine our understanding of cellular energy stress responses and provide a new framework for designing metabolic and autophagy research experiments.
-
Sabutoclax: Transforming Apoptosis Targeting in Translationa
2026-06-14
This thought-leadership article explores Sabutoclax as a next-generation pan-Bcl-2 inhibitor, blending mechanistic insight, in vitro/in vivo validation, and translational strategy. By integrating robust evidence, workflow innovation, and advanced viability metrics, it guides researchers aiming to overcome apoptosis resistance in cancer.
-
Vacuolin-1 in Lysosomal Exocytosis: Pathway Insights & Assay
2026-06-13
Discover how Vacuolin-1, a leading lysosomal exocytosis inhibitor, enables advanced dissection of lysosome-mediated membrane trafficking and growth factor signaling. This article uniquely connects molecular mechanism, disease relevance, and assay optimization for breakthrough research.
-
Decitabine in Cancer Epigenetics: Mechanistic Insights and T
2026-06-12
Explore the multifaceted role of Decitabine (5-Aza-2'-deoxycytidine) in cancer epigenetics. This article uniquely connects molecular mechanisms, emerging clinical strategies, and the translational power of DNMT1 inhibition for tumor suppressor gene reactivation.
-
HATU: Precision Peptide Coupling for Advanced Amide Synthesi
2026-06-12
HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) enables rapid, high-yield amide and ester formation, even in challenging peptide synthesis workflows. With APExBIO’s validated HATU, researchers achieve superior efficiency, minimized epimerization, and robust performance for complex synthetic targets.
-
BOP Reagent in Peptide Synthesis: Workflows & Troubleshootin
2026-06-11
BOP reagent streamlines high-fidelity peptide bond formation, excelling in phenyl ester and blocked derivative syntheses. Discover practical protocol parameters, advanced oncology applications, and troubleshooting strategies that maximize efficiency and product yield.
-
Plasmid-Mediated Carbapenem Resistance in Enterobacter cloac
2026-06-11
This study provides a detailed characterization of carbapenemase-encoding genes (CEGs) and their transmission among carbapenem-resistant Enterobacter cloacae (CREC) isolates from eight hospitals in Guangdong, China, during the COVID-19 pandemic. The findings highlight the dominance of plasmid-borne blaNDM-1, high multidrug resistance, and efficient horizontal gene transfer, informing resistance modeling and experimental design for multidrug-resistant bacteria.
-
HATU-Driven Peptide Synthesis: Unlocking Drug Discovery Fron
2026-06-10
Explore how HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) is transforming peptide synthesis chemistry and enabling the next generation of selective enzyme inhibitors. This thought-leadership article blends mechanistic insight, protocol guidance, and translational strategy, using recent advances in M1 aminopeptidase inhibitor research as a living case study.
-
Cell Divisions Refine Tissue Boundaries in Drosophila Embryo
2026-06-10
This study reveals that cell divisions in Drosophila embryos both challenge and refine tissue boundaries by increasing local tissue fluidity and enabling interface sharpening, independent of actomyosin tension. The findings provide new mechanistic insight into morphogenesis and have implications for understanding tissue compartmentalization and disease progression.
-
Cyclosporin A (SKU B1922): Technical Guidance for Research U
2026-06-09
Cyclosporin A is a well-characterized immunosuppressive agent relied upon for cell-based and animal studies investigating T-cell activation, apoptosis modulation, and mitochondrial function. This article outlines product-specific handling, protocol design, and troubleshooting guidance for researchers using Cyclosporin A in autoimmune disorder research, viral entry inhibition assays, and retinal ischemic injury models. Use is not recommended where water solubility or long-term solution stability are critical requirements.
-
Nonivamide: Capsaicin Analog for Advanced Cancer Assays
2026-06-09
Nonivamide, a potent capsaicin analog, is redefining cancer and neuroimmune research with its selective TRPV1 activation, robust anti-proliferative properties, and reproducible inflammation modulation. Discover optimized experimental workflows, troubleshooting insights, and translational advantages for maximizing impact with this APExBIO-supplied compound.
-
Peroxynitrite Drives ER Stress–Mediated Necroptosis in Cardi
2026-06-08
Liu et al. reveal that peroxynitrite generated during cardiac ischemia–reperfusion in hyperhomocysteinemia triggers ER stress and abnormal calcium transfer, ultimately driving necroptosis in cardiac microvascular endothelial cells. This mechanistic insight highlights the IP3R–Ca2+ axis as a tractable therapeutic target for acute cardiovascular injury.